10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-056994`
Period End Date	20200331
Filing Date	20200505
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	iova-20200331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 16 Cash Flow Statement 49 Stockholders Equity 20 Comprehensive Income 6

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.97M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$52.54M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$293.11M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$193.11M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.73M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.41M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$316.49M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$256.38M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.61M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.54M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.70M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$9.30M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$5.53M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$5.45M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.48M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.48M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	126.41M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	126.82M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	126.82M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	126.41M	shares	Point-in-time
Total Assets	`Assets`	$344.65M	USD	Point-in-time
Total Assets	`Assets`	$288.30M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.61M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$15.57M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$22.50M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$16.27M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$6.43M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$7.25M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$39.08M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$39.55M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$3.09M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$4.25M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$5.44M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$6.60M	USD	Point-in-time
Total Liabilities	`Liabilities`	$44.98M	USD	Point-in-time
Total Liabilities	`Liabilities`	$45.68M	USD	Point-in-time
Commitments and contingencies (Notes 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 126,823,156 and 126,411,808 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 126,823,156 and 126,411,808 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$912.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$220.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$882.60M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$869.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$300.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-570.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-640.21M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$434.93M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$243.31M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$298.97M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$466.19M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$288.30M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$344.65M	USD	Point-in-time

Income Statement 16 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	$30.91M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$56.95M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$13.86M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$9.08M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$70.81M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$39.99M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-39.99M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-70.81M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$1.22M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$3.04M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-69.59M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-36.95M	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.55	USD	1 Quarter
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	123,415.00	shares	1 Quarter
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	126,568.00	shares	1 Quarter

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-69.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.95M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.41M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$5.85M	USD	1 Quarter
Noncash lease expense	`NonCashLeaseExpense`	$1.87M	USD	1 Quarter
Noncash lease expense	`NonCashLeaseExpense`	$1.42M	USD	1 Quarter
Amortization of premiums on investments	`AmortizationOfDebtDiscountPremium`	$-1.23M	USD	1 Quarter
Amortization of premiums on investments	`AmortizationOfDebtDiscountPremium`	$-50.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$271.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$252.00K	USD	1 Quarter
Gain on settlement of dispute	`GainLossRelatedToLitigationSettlement`	$336.00K	USD	1 Quarter
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.32M	USD	1 Quarter
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.59M	USD	1 Quarter
Operating lease liabilities (Right-of-use assets)	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-2.46M	USD	1 Quarter
Operating lease liabilities (Right-of-use assets)	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-942.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-7.77M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.58M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-3.35M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$4.36M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-65.29M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-29.09M	USD	1 Quarter
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$91.04M	USD	1 Quarter
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$113.67M	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$12.92M	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$89.19M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$824.00K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$637.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$100.11M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.03M	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$71.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$118.00K	USD	1 Quarter
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$3.95M	USD	1 Quarter
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$69.00K	USD	1 Quarter
Net cash provided by / (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.00K	USD	1 Quarter
Net cash provided by / (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.83M	USD	1 Quarter
Net increase / (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-28.06M	USD	1 Quarter
Net increase / (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$38.65M	USD	1 Quarter
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$54.09M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.06M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period (Note 2)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period (Note 2)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$54.09M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period (Note 2)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period (Note 2)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$58.06M	USD	Point-in-time
Net unrealized gain on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$180.00K	USD	1 Quarter
Net unrealized gain on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$692.00K	USD	1 Quarter
Acquisitions of property and equipment included in accounts payable and accrued expenses	`LeaseholdImprovementsPaidByLandlord`	$268.00K	USD	1 Quarter
Acquisitions of property and equipment included in accounts payable and accrued expenses	`LeaseholdImprovementsPaidByLandlord`	$4.69M	USD	1 Quarter

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$434.93M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$243.31M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.41M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.85M	USD	1 Quarter
Vesting of restricted shares issued for services	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$1.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-71.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-118.00K	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$69.00K	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.95M	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$180.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$692.00K	USD	1 Quarter
Cancellation of common shares from settlement of dispute	`StockCancelledDuringPeriodSharesOfCommonStock`	$-336.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-69.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-36.95M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$434.93M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$243.31M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time

Comprehensive Income 6 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-69.59M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-36.95M	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$180.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$692.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-68.90M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-36.77M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.